Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain
Mezquita-Raya, Pedro, Ramírez de Arellano, Antonio, Kragh, Nana, Vega-Hernandez, Gabriela, Pöhlmann, Johannes, Valentine, William J., Hunt, BarnabyVolume:
8
Language:
english
Journal:
Diabetes Therapy
DOI:
10.1007/s13300-017-0239-6
Date:
April, 2017
File:
PDF, 775 KB
english, 2017